While precision seems critical for science, researchers from the U.S. Department of Energy's (DOE) Brookhaven National ...

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

The safest, most creator-first AI platform—built to protect likeness, intellectual property, and enterprise-grade content at scale.

Bio (NASDAQ:IBIO) is seeking to narrow what it views as a growing “trust gap” between the promise of generative AI in drug discovery and the high cost and long timelines of bringing a drug to market, ...

Shadow AI 2.0 isn’t a hypothetical future, it’s a predictable consequence of fast hardware, easy distribution, and developer ...

The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the ...

The words on this page mean something because they are assembled in a particular order and follow the complex rules of grammar and syntax. Creating new chemical polymers follows a similar kind of ...

Generative AI in Gaming Is Here, but Facing Pushback From Gamers — and Developers ...

You can hear AI give you mental health advice, rather than merely seeing the advice via text. Think of the real-time upside.

The generative AI models used in classified environments can answer questions but don't currently learn from the data they see. That could soon change. The Pentagon is discussing plans to set up ...

According to MarketsandMarkets™, the Generative AI Server Market is expected to reach USD 448.60 billion by 2030 from USD 103.92 billion in 2025, registering a CAGR of 34.0% during the forecast period ...